These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 20681354)
21. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD). Del Casale A; Sorice S; Padovano A; Simmaco M; Ferracuti S; Lamis DA; Rapinesi C; Sani G; Girardi P; Kotzalidis GD; Pompili M Curr Neuropharmacol; 2019; 17(8):710-736. PubMed ID: 30101713 [TBL] [Abstract][Full Text] [Related]
22. Psychosocial treatment for obsessive-compulsive disorder. Munford PR; Hand I; Liberman RP Psychiatry; 1994 May; 57(2):142-52. PubMed ID: 7938333 [TBL] [Abstract][Full Text] [Related]
23. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder. Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069 [TBL] [Abstract][Full Text] [Related]
24. [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors]. Arias Horcajadas F; Soto JA; García-Cantalapiedra MJ; Rodríguez Calvin JL; Morales J; Salgado M Actas Esp Psiquiatr; 2006; 34(3):147-52. PubMed ID: 16736387 [TBL] [Abstract][Full Text] [Related]
25. The future of pharmacotherapy for obsessive-compulsive disorder may lie in a better understanding of its heterogeneity. Brakoulias V Expert Opin Pharmacother; 2014 Jul; 15(10):1321-3. PubMed ID: 24866422 [TBL] [Abstract][Full Text] [Related]
26. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders]. Nakamae T Seishin Shinkeigaku Zasshi; 2011; 113(10):1016-25. PubMed ID: 22187889 [TBL] [Abstract][Full Text] [Related]
27. A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Talaei A; Hosseini FF; Aghili Z; Akhondzadeh S; Asadpour E; Mehramiz NJ; Forouzanfar F Can J Physiol Pharmacol; 2020 Apr; 98(4):236-242. PubMed ID: 32228235 [TBL] [Abstract][Full Text] [Related]
35. A review of the treatment for refractory obsessive-compulsive disorder: from medicine to deep brain stimulation. Husted DS; Shapira NA CNS Spectr; 2004 Nov; 9(11):833-47. PubMed ID: 15520607 [TBL] [Abstract][Full Text] [Related]
36. [Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia]. Scholl HP; Kasper S; Danos P; Höflich G; Möller HJ Nervenarzt; 1994 Jul; 65(7):478-81. PubMed ID: 7800092 [TBL] [Abstract][Full Text] [Related]
37. A single-blinded case-control study of memantine in severe obsessive-compulsive disorder. Stewart SE; Jenike EA; Hezel DM; Stack DE; Dodman NH; Shuster L; Jenike MA J Clin Psychopharmacol; 2010 Feb; 30(1):34-9. PubMed ID: 20075645 [TBL] [Abstract][Full Text] [Related]
38. Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder. Marazziti D; Pallanti S Am J Psychiatry; 1999 Nov; 156(11):1834-5. PubMed ID: 10553756 [No Abstract] [Full Text] [Related]
39. Effect of Ziprasidone Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: A 12-Week, Open-Label Uncontrolled Preliminary Study. Bruno A; Pandolfo G; Cedro C; Gallo G; De Felice M; Zoccali RA; Muscatello MR Clin Neuropharmacol; 2016; 39(1):6-9. PubMed ID: 26757309 [TBL] [Abstract][Full Text] [Related]
40. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]